within Pharmacolibrary.Drugs.C_CardiovascularSystem.C08D_SelectiveCalciumChannelBlockersWithDirectCardiacEffects.C08DB01_Diltiazem;
model Diltiazem 
   extends Pharmacolibrary.Drugs.ATC.C.C08DB01;

  annotation(Documentation(
    info ="<html><body><p>Diltiazem is a non-dihydropyridine calcium channel blocker (class IV antiarrhythmic) used to treat hypertension, angina pectoris, and certain types of cardiac arrhythmias such as atrial fibrillation or supraventricular tachycardia. It is an approved prescription medication and widely used clinically.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers (both sexes, age 18–65 years) after oral administration in a crossover study.</p><h4>References</h4><ol><li><p>Kinney, EL, et al., &amp; Zelis, R (1981). The pharmacokinetics and pharmacology of oral diltiazem in normal volunteers. <i>Journal of clinical pharmacology</i> 21(8-9) 337–342. DOI:<a href=&quot;https://doi.org/10.1002/j.1552-4604.1981.tb01778.x&quot;>10.1002/j.1552-4604.1981.tb01778.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7276227/&quot;>https://pubmed.ncbi.nlm.nih.gov/7276227</a></p></li><li><p>Murata, K, et al., &amp; Samejima, M (1989). Pharmacokinetics of an oral sustained-release diltiazem preparation. <i>Journal of pharmaceutical sciences</i> 78(11) 960–963. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600781116&quot;>10.1002/jps.2600781116</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2621582/&quot;>https://pubmed.ncbi.nlm.nih.gov/2621582</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Diltiazem;
